During the past decade, Albert Schweitzer Ziekenhuis, Locatie Dordwijk conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk" #1 sponsor was "Bayer" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Wellspect HealthCare" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk" are "Multiple Myeloma" (2 trials), "Acute Myocardial Infarction" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Kidney Disease" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk" in a lesser frequency.

Most popular intervention types in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk" are "Drug" (9 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Anastrozole" (1 trials) and "BAY1213790 (Osocimab)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Albert Schweitzer Ziekenhuis, Locatie Dordwijk". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Albert Schweitzer Ziekenhuis, Locatie Dordwijk, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Schweitzer Ziekenhuis, Locatie Dordwijk, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".